RAP
Click for more information
0.00% 20.5¢ resapp health limited

Poor management of the trials pivotal in achieving FDA approval...

  1. silverfox3731
    3,601 Posts.
    lightbulb Created with Sketch. 724
    clock Created with Sketch.
    21/06/22
    13:03
    Post #: 62112385
    Poor management of the trials pivotal in achieving FDA approval years ago, using sound dependent smartphones in noisy USA hospitals to record paediatric coughs are now capped off again by a sloppy performance. Shareholders ought feel outraged by this performance.
    Sorry for Professor Abeyratne whose amazing technology has been mismanaged.
    FOX
    RAP Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 20  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.